Scientific advancements are critical for unlocking incredible breakthroughs in global health. That's why ATCC is committed to providing researchers with the credible, cutting-edge models they need to make breakthroughs in diagnostics development, drug discovery, and translational research.
Through targeted acquisitions, we are able to provide researchers with clinically relevant microorganisms and patient-derived cell lines that support important public health initiatives such as antimicrobial resistance, infectious disease, and cancer research. We also conduct our own internal research using the latest techniques and technologies to drive the development of innovative products that provide greater specificity and functionality to the researcher's toolkit.
Explore our newest products below to discover how we can collaborate on your next project, and be sure to check out our resources for detailed product application data.
Browse Our Featured Portfolios
MicroQuant™
Streamline your microbial QC testing with best-in-class microbial controls provided in a single-use format that is precisely quantitated, rehydrates rapidly, and can be conveniently stored at 2-8°C.
HCMI Cancer Models
We are continually adding 2-D and 3-D patient-derived cancer models to our portfolio. These next-generation models include both common as well as rare and understudied examples of cancer from numerous tissues.
